1. United States of America Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
Blue Water Ventures International, Inc.

Blue Water Ventures International, Inc.

BWVI
Blue Water Ventures International, Inc.US flagOther OTC
0.00
USD
- -
- -
24,407.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
TTM
Revenue per Share
0.18
0.14
0.18
0.24
0.54
1.54
1.13
0.79
0.9
Basic EPS, GAAP
-1.67
-0.03
-0.1
-0.02
-0.75
-0.47
0.02
-0.25
-0.12
Free Cash Flow per Basic Share
0.06
0.05
0.03
0.05
-0.77
0.03
0.18
0.01
0.14
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.67
-1.52
-1.46
-0.03
-0.81
-1.17
-1.15
-1.39
-1.3
Tangible Book Value per Share
0.25
0.32
0.31
-1.41
-0.24
-0.63
-0.03
-0.14
-0.03
Basic Weighted Avg Shares
- -
- -
- -
1
1
1
1
1
1
Sales/Revenue/Turnover
- -
- -
- -
- -
1
2
1
1
1
Operating Margin (%)
-941.15
-18.45
-88.39
-24.26
-195.17
-17.01
-10.13
-26.85
-9.91
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
96.51
Profit Margin (%)
-941.15
-18.45
-57.24
-10.45
-138.77
-30.71
1.85
-31.66
-12.92
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
1
- -
1
- -
- -
- -
Total Equity
- -
- -
- -
- -
1
1
1
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
28.88
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'11
Dec'11
Mar'12
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Sep'11
Dec'11
Mar'12
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
2
Payables & Accruals
1
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
107.68%
-48.05%
Free Cash Flow
- -
-198.54%
-97.15%
Net Income, GAAP
- -
358.15%
-1,291.13%
Sales/Revenue/Turnover
- -
140.63%
-30.52%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
1
- -
- -
- -
1
2011
- -
- -
- -
- -
1
2012
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
0.05
0.45
-0.02
- -
0.02
2011
-0.04
-0.1
-0.12
- -
-0.25
2012
0.09
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Neilank K. Jha
Full Time Employees
5
Sector
Industrials
Industry
Specialty Business Services
Address
515 E. Las Olas Blvd Fort Lauderdale FL United States of America 32043
IPO Date
Jun 1, 2007
CIK
0001310291
Website
psycheceutical.com
Similar Companies
Cellnet Group Limited (CLT.AX)
Caverion Oyj (CAV1V.HE)
Haidemenos S.A. (HAIDE.AT)
Orion Diversified Holding Co. Inc. (OODH)
Walchand PeopleFirst Limited (WALCHPF.BO)
JMC Corporation (5704.T)
Business
Blue Water Ventures International, Inc. (BWVI) is an environmentally responsible global exploration company specializing in marine surveys, marine archaeology, and historical shipwreck research and recovery using archaeologically sound methods and state-of-the-art technology targeting sites primarily in North and Central America, including the Caribbean. The company provides shallow ocean historic shipwreck exploration services; conducts recovery operations on wrecks such as the SS Pulaski expedition off the coast of North Carolina; offers marine surveys; and sells treasure and nautical-themed jewelry re-creations incorporating recovered artifacts. Founded in 2006 and headquartered in Fort Lauderdale, Florida, BWVI operates through its subsidiary Psycheceutical Inc., which develops pharmaceutical products and technologies for mental health treatments, including psychedelic medicine; it previously focused on shipwreck location data acquisitions and recovery efforts in international waters. In recent developments, BWVI signed a non-binding letter of intent for the acquisition of Psycheceutical Inc. to advance its biopharmaceutical pivot; announced expectations to receive $10 million in funding through common stock issuance in June 2024; and maintains ongoing projects like the SS Pulaski expedition while listed on OTC Markets. The company targets investors and historical preservation interests, with principal executive offices at 515 E. Las Olas Blvd., Suite 120, Fort Lauderdale, FL 33301.

Company News

APIChatGPT

  • accesswire.com

    Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences

  • accesswire.com

    Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space

  • accesswire.com

    Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.

  • accesswire.com

    Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD

  • accesswire.com

    Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy

  • accesswire.com

    First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD